Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
armodafinil
Teva Pharma Australia Pty Ltd
armodafinil
Registered
NUVIGIL ® _Armodafinil_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about NUVIGIL tablets. As this leaflet does not contain all the available information, it is important that you talk to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you receiving NUVIGIL against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT NUVIGIL IS USED FOR NUVIGIL is used to improve wakefulness in people with excessive daytime sleepiness associated with the medical condition known as narcolepsy or with Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS), or shift work sleep disorder (SWSD). In narcolepsy, there is a sudden and irresistible tendency to fall asleep during normal waking hours. This happens at unpredictable times, even when it is inappropriate or may be unsafe to do so. NUVIGIL decreases this unwanted excessive daytime sleepiness. With OSAHS, daytime sleepiness may occur due to an interrupted night time sleep. NUVIGIL only treats the symptom of sleepiness and does not treat the cause of OSAHS. Whilst taking NUVIGIL you should continue with treatments intended to help manage your underlying medical condition, such as Continuous Positive Airway Pressure, unless your doctor tells you otherwise. If you have been diagnosed with moderate to severe chronic Shift Work Sleep Disorder (SWSD) and non-drug therapies have been unsuitable or unsuccessful, NUVIGIL may be prescribed to keep you awake during your work shift. Precisely how NUVIGIL works is not known, but it is known that it acts on the central nervous system (the brain). It differs from other stimulant medicines that promote wakefulness. NUVIGIL increases wakefulness. Your doctor may have prescribed NUVIGIL for another reason. Ask your doctor if you have any questions about why NUVIGIL has been prescribed for you. BEFORE YOU Přečtěte si celý dokument
Teva Pharma Australia Pty Ltd Version 7.0 1 Based on CCSI: 794/02/07/16 AUSTRALIAN PRODUCT INFORMATION – NUVIGIL ® (ARMODAFINIL) TABLETS 1 NAME OF THE MEDICINE Armodafinil 2 QUALITATIVE AND QUANTITATIVE COMPOSITION NUVIGIL® tablets contain 50, 150 or 250 mg of armodafinil. NUVIGIL® tablets contain lactose monohydrate. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM The appearance of NUVIGIL® tablets are as follows: 50 mg: Each round, white to off-white tablet is debossed with on one side and “205” on the other. 150mg: Each oval, white to off-white tablet is debossed with on one side and “215” on the other. 250mg: Each oval, white to off-white tablet is debossed with on one side and “225” on the other 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS NUVIGIL® is indicated: to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy; to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate; as an adjunct to continuous positive airways pressure (CPAP) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness. 4.2 D OSE AND METHOD OF ADMINISTRATION NUVIGIL® (armodafinil) is for oral administration. NUVIGIL® should be used only in patients who have had a complete evaluation of their excessive sleepiness, and in whom a diagnosis of the underlying disorder of narcolepsy, OSAHS, or SWSD has been made in accordance with ICSD or DSM diagnostic criteria. Such an evaluation usually consists Teva Pharma Australia Pty Ltd Version 7.0 2 Based on CCSI: 794/02/07/16 of a complete history and physical examination, and it may be supplemented with testing in a laboratory setting. Some patients may have more than one sleep disorder contributing to their excessive sleepiness (e.g., OSAHS and SWSD coincident in the same patient). NUVIGIL® may be taken with or without food, however administ Přečtěte si celý dokument